Pharmaceutical Research & Manufacturers of America

Pharmaceutical Research & Manufacturers of America's disclosed federal lobbying spend of $135.8M places it in the megaspender tier — the small set of organizations that have crossed nine figures in cumulative reported lobbying outlays. Spending at this scale typically means a permanent in-house government affairs office, a roster of outside lobbying firms on retainer, and active engagement on dozens of separate policy items in any given year.

Across the 5-year window from 2020 to 2024, Pharmaceutical Research & Manufacturers of America's annual disclosed lobbying spend has declined modestly — from $25.9M in 2020 to $24.6M in 2024, a change of -5%. Step-changes of this size often coincide with major bills moving through Congress, regulatory rulemakings affecting the organization's industry, or a leadership change in the relevant committee.

Pharmaceutical Research & Manufacturers of America's disclosed lobbying covers 9 general issue areas — a moderate footprint. Filers in this range tend to engage on a coherent cluster of related topics rather than spreading effort across the federal agenda.

27 of 60 lobbyists reported by Pharmaceutical Research & Manufacturers of America (45%) disclose prior federal government service. That share is common at established government affairs operations that explicitly hire from agency and committee staff.

Among the named bench, lobbyists with disclosed prior federal service include Emily B. Parker (Former Special Assistant, National Security Council); Amanda D. Morris (Former Professional Staff Member, Senate Armed Services Committee); Timothy C. Grady (Former Staff Director, House Energy & Commerce Committee). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.

Within the Pharmaceutical & Health Products sector, Pharmaceutical Research & Manufacturers of America ranks #1 of 34 tracked organizations by disclosed lobbying spend. The sector leader is Pharmaceutical Research & Manufacturers of America at $135.8M; the sector average is $16.7M. Pharmaceutical Research & Manufacturers of America's $135.8M sits 713% above the sector average.

Pharmaceutical Research & Manufacturers of America's LobbySpend Influence Score of 77/100 (grade B) reflects significant federal lobbying reach. The score blends disclosed total spend, issue breadth, and revolving-door connections — lobbyists with prior federal government service. A B-grade typically means the organization is well above average on at least two of those three signals, with sustained activity over multiple years rather than a one-off spike.

Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.